BIIB vs DOMO · P/E 21, rev $9.89B vs rev $318.9M
Biogen Inc (BIIB) versus Domo Inc (DOMO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Domo Inc (DOMO) is a software - application company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported DOMO revenue for 2026-01-31 was $318.9M. Net income was -$59.3M. Revenue was up 0.6% from 2025-01-31 to 2026-01-31. DOMO currently screens at market cap $559.7M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. DOMO currently screens at market cap $559.7M.
Not investment advice. Open the BIIB and DOMO stock pages for the full models.
Not investment advice.